Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

European Commission extends Alimta approval

Oct. 28, 2011

Researchers at Abbott claim novel inhibitors of Bcl-2

Oct. 28, 2011

Marina Biotech presents novel nucleic acid complexes

Oct. 28, 2011

TopoTarget patents new nicotinamide phosphoribosyltransferase inhibitors

Oct. 28, 2011

New Wnt signaling inhibitors discovered in Germany

Oct. 28, 2011

Adventrx and FDA agree on pivotal ANX-514 trial

Oct. 28, 2011

S*BIO plans phase III program for pacritinib

Oct. 27, 2011

Solasia Pharma begins study of darinaparsin injection in Japan

Oct. 27, 2011

Immunovaccine clear to start phase I/II DPX-Survivac trial in Canada

Oct. 27, 2011

Avila Therapeutics describes new BTK inhibitor

Oct. 27, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....